Excellent opening panel at #CPIC2019 on the practical considerations for choosing a testing platform/lab. Takeaways: panel standardization and reference materials needed, transparency in results reporting and limitations a must, *1/*1 not necessarily normal. CPIC PharmGKB

Exciting start to the CPIC 2019 conference! PharmCAT live and online to beta test translation of vcf genotype files for pharmacogenomics! pharmcat.org #CPIC2019 CPIC

Recently published article helping clinicians navigate pharmacogenetic test selection ascpt.onlinelibrary.wiley.com/doi/full/10.10…. CPIC #CPIC2019

One of Jeff Bishop’s ⁦UMN Pharmacy final slides at ⁩#cpic2019 - really like the #Pharmacist mention here - once again highlighting point that pharmacists can use #pharmacogenomics as one more tool for patient care and managing drug therapy ⁦St. Jude Research⁩

Elegant presentation from Jeff Bishop, PharmD at #CPIC2019. Pts with polymorphisms conferring poor or ultra rapid metabolism are 3-6x more likely to discontinue antidepressant treatment at 45 days or 1 yr CPIC

Here are more resources on St. Jude Research experience implementing preemptive #pharmacogenomics #CPIC2019 Implementation Resources for Professionals - St. Jude Children’s Research Hospital stjude.org/research/clini…

CPIC leader & co-PI Mary Relling closes #CPIC2019 with a look at CPIC's future including new tools (database, API), phase 2 of the term standardization project & work with external resources including ClinGen & ClinVar #pharmacogenetics

Great news! U.S. FDA approved #daratumumab w/ lenalidomide & dexamethasone for patients w/ newly diagnosed #MultipleMyeloma who are ineligible for autologous stem cell transplantation. And our own Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 was a lead investigator for this study! #MyLCI bddy.me/2XbemiI

Annotated #pharmacogenomic dosing guidelines from CPIC, DPWG & CPNDS as well as other professional organizations can be found on our Dosing Guidelines pages pharmgkb.org/guidelines #PrecisionMedicine #clinicians

We're happy to announce Andy Crowder as our new SVP and Chief Information and Analytics Officer, effective July 15. Information and analytics play an important role in caring for our patients, and he will now lead this strategy. Welcome, Andy! More: bit.ly/2XJPZsK

CPIC co-PI Mary Relling is a co-author on two reviews in this month's issue of The Lancet. An intro to #pharmacogenomics ncbi.nlm.nih.gov/pubmed/31395440 & advice on implementing #genomic #medicine in the #clinic ncbi.nlm.nih.gov/pubmed/31395439.

Glad to see greater emphasis on VTE screening, prophylaxis, and incorporation of DOACs in the new ASCO VTE treatment and prophylaxis guidelines! ascopubs.org/doi/full/10.12…. Honored to be part of the CASSINI team nejm.org/doi/full/10.10…

"AMP has endorsed CPIC’s Term Standardization for Clinical #Pharmacogenetics Test Results Project and encourages the use of CPIC’s gene-drug practice guidelines." #PGx

Novel KRAS inhibitor induces disease control in 96% of treated patients with non-small cell #lungcancer #WCLC19 Amgen 🧪🔬🧬 Siteman Cancer Center healio.com/hematology-onc…

Our latest blog post outlines the most significant changes resulting from the #CYP2D6 standardization project. A must-read for anyone working in #PGx testing or implementation pharmgkb.blogspot.com/2019/11/cyp2d6… #PrecisionMedicine #genetics

We are one of just 5 cancer institutes in the country to be recognized by the European Society of Medical Oncology as a Designated Center of Integrated Oncology and Palliative Care! This honor reflects a high standard of integration of medical oncology and palliative care.

Genomic Medicine Year in Review 2019: What’s Hot for Public Health Impact? Check it out! blogs.cdc.gov/genomics/2019/…

Phenotype-guided dosing of prophylactic voriconazole may reduce fungal infections & costs according 2 studies published in ASCPT Alexandria led by researchers from Levine Cancer & Moffitt Cancer Center bit.ly/3cxOuGD Jai Patel

#Pharmacogenomics helps determine how an individual’s genes affect response to specific drugs. Dr. Jai Patel reinforced the need for testing in oncology & challenges in his presentation to our Council. Read more in ORION by VieCure: viecure.com/cac-highlight-…

We are thrilled to share that the research done by the lung bus team, including the president of LCI, Dr. Derek Raghavan & our Disparities and Outreach team is recognized as one of the most significant efforts in the world to reduce cancer deaths in high-risk populations. #ASCO21